ATE96320T1 - Castanospermin-ester zur hemmung der tumormetastasierung. - Google Patents

Castanospermin-ester zur hemmung der tumormetastasierung.

Info

Publication number
ATE96320T1
ATE96320T1 AT89123189T AT89123189T ATE96320T1 AT E96320 T1 ATE96320 T1 AT E96320T1 AT 89123189 T AT89123189 T AT 89123189T AT 89123189 T AT89123189 T AT 89123189T AT E96320 T1 ATE96320 T1 AT E96320T1
Authority
AT
Austria
Prior art keywords
inhibition
tumor metastasis
castanospermine ester
castanospermine
ester
Prior art date
Application number
AT89123189T
Other languages
English (en)
Inventor
Sai P Sunkara
Paul S Liu
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE96320T1 publication Critical patent/ATE96320T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT89123189T 1988-12-15 1989-12-14 Castanospermin-ester zur hemmung der tumormetastasierung. ATE96320T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/284,510 US4952585A (en) 1988-12-15 1988-12-15 Castanospermine esters in the inhibition of tumor metastasis
EP89123189A EP0373663B1 (de) 1988-12-15 1989-12-14 Castanospermin-ester zur Hemmung der Tumormetastasierung

Publications (1)

Publication Number Publication Date
ATE96320T1 true ATE96320T1 (de) 1993-11-15

Family

ID=23090466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89123189T ATE96320T1 (de) 1988-12-15 1989-12-14 Castanospermin-ester zur hemmung der tumormetastasierung.

Country Status (12)

Country Link
US (1) US4952585A (de)
EP (1) EP0373663B1 (de)
JP (1) JP2963476B2 (de)
KR (1) KR0135278B1 (de)
AT (1) ATE96320T1 (de)
AU (1) AU621431B2 (de)
DE (1) DE68910287T2 (de)
DK (1) DK634689A (de)
ES (1) ES2061912T3 (de)
IE (1) IE62014B1 (de)
PH (1) PH26024A (de)
ZA (1) ZA899451B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US4970317A (en) * 1989-08-08 1990-11-13 Merrell Dow Pharmaceuticals Inc. Process for the preparation of castanospermine esters
CA2287316C (en) * 1997-05-22 2005-02-08 Hoechst Marion Roussel, Inc. Process for preparing 6-o-monoesters of castanospermine
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
US6013459A (en) * 1997-06-12 2000-01-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
US8226684B2 (en) * 2008-12-22 2012-07-24 Ethicon, Inc. Surgical sutures having collapsible tissue anchoring protrusions and methods therefor
US8703744B2 (en) * 2009-03-27 2014-04-22 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
WO2017138008A2 (en) * 2016-02-14 2017-08-17 Yeda Research And Development Co. Ltd. Methods of modulating protein exocytosis and uses of same in therapy
WO2018059214A1 (zh) 2016-09-29 2018-04-05 广州君赫生物科技有限公司 影响saicar合成的化合物及应用
US11684593B2 (en) 2017-04-20 2023-06-27 Geneheal Biotechnology Co., Ltd. Applications of spermine and its derivative in preparation of antitumor drug
CA3064486C (en) 2017-04-20 2023-08-01 Geneheal Biotechnology Co., Ltd. Applications of spermidine and its derivatives
US12605349B2 (en) 2024-09-05 2026-04-21 Orbus Therapeutics, Inc. Methods of treating grade 3 astrocytoma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792558A (en) * 1987-05-29 1988-12-20 Merrell Dow Pharmaceuticals Inc. Castanospermine for inhibiting tumor metastasis
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
AU618838B2 (en) * 1988-08-10 1992-01-09 Praxis Pharmaceuticals, Inc. Use of castanospermine as an anti-inflammatory and immunosuppressant agent

Also Published As

Publication number Publication date
DE68910287T2 (de) 1994-03-10
AU621431B2 (en) 1992-03-12
DK634689A (da) 1990-06-16
IE894009L (en) 1990-06-15
DK634689D0 (da) 1989-12-14
ES2061912T3 (es) 1994-12-16
EP0373663A2 (de) 1990-06-20
AU4670789A (en) 1990-06-21
EP0373663B1 (de) 1993-10-27
JP2963476B2 (ja) 1999-10-18
EP0373663A3 (en) 1990-09-12
US4952585A (en) 1990-08-28
KR0135278B1 (ko) 1998-04-23
IE62014B1 (en) 1994-12-14
JPH02212427A (ja) 1990-08-23
PH26024A (en) 1992-01-24
KR910011256A (ko) 1991-08-07
ZA899451B (en) 1990-09-26
DE68910287D1 (de) 1993-12-02

Similar Documents

Publication Publication Date Title
ATE96320T1 (de) Castanospermin-ester zur hemmung der tumormetastasierung.
GR3035526T3 (en) Retroviral protease inhibitors.
DE3673161D1 (de) Renininhibitoren und verfahren zur anwendung derselben.
LU88797I2 (fr) Raltitrexed et ses sels esters et hydrates pharmaceutiquement acceptables
LT2063B (lt) Guanino dariniu arba ju farmaceutiskai tinkamu drusku gavimo budas
LU91173I2 (fr) Ximelagatran, et les sels pharmaceutiquement acceptables de celui-ci (exanta).
NO920586L (no) Fremgangsmaate for regulering av produksjonen av en petroleumsbroenn
ITMI920045A1 (it) Macchina posabinario per l'abbassamento controllato di un binario
FI934566A7 (fi) Fenoli-2-piperidino-1-alkanolien prodrugesterit
NO930829L (no) Fremgangsmaate for fremstilling av klavulansyresalter
ATA106786A (de) Verfahren zur herstellung der neuen 7-amino-3propenylcephalosporansaeure sowie von estern und salzen derselben
OA09027A (fr) Procédé d'inhibition. d'un virus
FI893909A0 (fi) Menetelmä polymeerikuonan muodostumisen estämiseksi
ES556465A0 (es) Un procedimiento para la preparacion de nuevos acidos cefalosporanicos y sus esteres.
NO861497L (no) Fremgangsmaate til optisk spalting av racemiske blandinger av alfa-naftylpropionsyrer.
FI911855A0 (fi) Menetelmä anti-inflammatorisesti vaikuttavien 3-asyyli-2-oksindoli-1-karboksiamidi-esilääkkeiden valmistamiseksi
ATE163856T1 (de) Verwendung eines direkten inhibitors von thrombin zur herstellung eines arzneimittels mit thrombolytischer aktivität
FI101963B1 (fi) Menetelmä raseemisen ja optisesti aktiivisen 1,2,3,4-tetrahydroisokinoliini-3-karboksyylihapon sekä sen esituotteiden valmistamiseksi
IT8448082A0 (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione
IT1186396B (it) Sistema per la creazione di un effetto pseudostereo nella riproduzione di suone monofonico
NO862990D0 (no) Fremgangsmaate til forming av plastiske naeringsmiddelmasser
ATE100710T1 (de) Eperisone als hypotonikum.
IT1217633B (it) Procedimento per la fabbricazione di un nastro di chiusura lampo
IT1190135B (it) Procedimento per la produzione di 10 metossi-6-metil-ergolin-derivati e di loro sali di addizione con acidi
DK124281A (da) Fremgangsmaade til fremstilling af vinca-dimere og farmaceutissk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee